The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have taken steps to simplify COVID-19 vaccination recommendations. Bivalent mRNA vaccines are now recommended for everyone age 6 months and older, and adults age 65 years and older and those with compromised immune systems may be eligible for an additional bivalent dose.

In this episode of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID), talks with NFID Executive Director and CEO Marla Dalton, CAE, about the new recommendations, explaining the changes and who is affected, as well as what might be in store for the upcoming 2023-2024 US respiratory season.

COVID-19 has not gone away. It is sobering to realize that 200-300 people still die every day due to COVID-19. We are all going to have to keep our guard up in order to ensure that we do not have another pandemic this winter.

NFID Medical Director William Schaffner, MD

Additional Resources from NFID:

Find answers to frequently asked questions about COVID-19, COVID-19 vaccines, and COVID-19 vaccination for children
To learn more about recent scientific research on vaccines for COVID-19 as well as influenza, respiratory syncytial virus (RSV), and the future of vaccinology, attend the online 2023 Annual Conference on Vaccinology Research (ACVR) on June 5-7, 2023
Join Dalton and Schaffner for the NFID Infectious IDeas podcast series, featuring thought-provoking conversations with leading experts, inspiring leaders, and pioneers in the field (new episodes drop the first Wednesday of every month)

Listen on Apple Podcastsr

Listen on Spotify

To join the conversation and get the latest news on infectious diseases, follow NFID on Twitter, like us on Facebook, follow us on Instagram, visit us on LinkedIn, listen and subscribe to the Infectious IDeas podcast, and subscribe to receive future NFID Updates.